ABOUT ORAL LIQUIDS

pentobarbital will decrease the extent or outcome of pitolisant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Watch Carefully. Pitolisant exposure is reduced by fifty% if coadministered with solid CYP3A4 inducers.Hypnotic doses of these barbiturates usually do not surface to considerably impair uterine action for the du